Literature DB >> 11769824

Antipsychotic induced hyperprolactinaemia: a series of illustrative case reports.

P M Haddad1, J S Hellewell, A Wieck.   

Abstract

Hyperprolactinaemia is a common side-effect of many antipsychotic drugs but, in comparison to extrapyramidal side-effects, it has received little attention. Four case reports are presented which illustrate important clinical and pharmacological aspects of the syndrome. Two of the cases were caused by conventional antipsychotic drugs and two by risperidone, an atypical antipsychotic. Symptoms included gynaecomastia, galactorrhoea, amenorrhoea and sexual dysfunction. Three patients were switched to a prolactin sparing antipsychotic leading to normalization of serum prolactin and resolution of the symptoms. Patients prescribed prolactin elevating antipsychotics should, where possible, have this issue explained to them prior to commencing treatment and be screened for symptoms suggestive of hyperprolactinaemia before starting treatment and regularly thereafter.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11769824     DOI: 10.1177/026988110101500408

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  6 in total

1.  Quality of life and adverse effects of olanzapine versus risperidone therapy in patients with schizophrenia.

Authors:  Katarina Melo Chaves; Antoni Serrano-Blanco; Susana Barbosa Ribeiro; Luiz Alberto Lira Soares; Gerlane Coelho Bernardo Guerra; Maria do Socorro Costa Feitosa Alves; Raimundo Fernandes de Araújo Júnior; Vanessa de Paula Soares Rachetti; Antônio Filgueira Júnior; Aurigena Antunes de Araújo
Journal:  Psychiatr Q       Date:  2013-03

Review 2.  Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.

Authors:  Peter M Haddad; Angelika Wieck
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  Adverse effects of atypical antipsychotics : differential risk and clinical implications.

Authors:  Peter M Haddad; Sonu G Sharma
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 4.  Is Adjunct Aripiprazole Effective in Treating Hyperprolactinemia Induced by Psychotropic Medication? A Narrative Review.

Authors:  Frank M C Besag; Michael J Vasey; Iffah Salim
Journal:  CNS Drugs       Date:  2021-04-20       Impact factor: 5.749

Review 5.  Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies.

Authors:  Peter M Haddad; Cecilia Brain; Jan Scott
Journal:  Patient Relat Outcome Meas       Date:  2014-06-23

6.  Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).

Authors:  Deanna L Kelly; Heidi J Wehring; Amber K Earl; Kelli M Sullivan; Faith B Dickerson; Stephanie Feldman; Robert P McMahon; Robert W Buchanan; Dale Warfel; William R Keller; Bernard A Fischer; Joo-Cheol Shim
Journal:  BMC Psychiatry       Date:  2013-08-22       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.